(the limits of the price tag isnt even clear yet)
this post was submitted on 24 Jun 2023
1 points (100.0% liked)
nyt_news
10 readers
1 users here now
Articles from The New York Times
founded 1 year ago
I'm ok if people with money want to throw their money at experimental treatments to try. I do take issue with locking life saving medicine behind high price tags.
The article mentions Ozempic and Wegovy which are new weight loss drugs (originally intended for diabetics), I believe I read in a different article that those cost $10k/yr. From my understanding, most of the use of them have been for fad weight loss instead of it going to the people that it was intended for (and might need it). Insurance is already a pain when it comes to medications, I'm sure for medications like this where its a fad medication on top of having legitimate uses it is even harder to get insurance to pay.
inb4 articles like: "America, and its great pay wall"
Certainly the genome diagnostics in the last year has made masses diffence I know many families that were without diagnosis for decades getting the exact gene wrong over last 3 years
I look forward to more advances in genome research and diagnostics. Although we may be several more decades out before seeing treatment plans make it through research and FDA trials